Replies to post #96063 on $heff's $tation of $tocks & $olid DD

[kei]

MRNS - that was a quick gain $heff! (just hit as high as $1.58 area after-hour ..unreal!)

[Mark]

Congrats $heff, I wanted to enter this am but was tied up on other trades and lost track of it. Monster move today.

[$heff]

New Economy Portfolio Update..Alert..exited remainder 2% position of $MRNS this morning at $1.36. It got to $1.53 in the AH yesterday. This morning opened much lower.

Disclaimer:..http://bit.ly/OlN9DB

[crudeoil24]

MRNS > 1.76 up 52% > RADNOR, Pa., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), today announced positive preliminary data from the initial CDKL5 patients enrolled in its ongoing Phase 2 open-label study evaluating its CNS-selective GABA(A) modulator, ganaxolone, as a treatment for orphan, genetic disorders. CDKL5 is a severe, rare genetic disorder that results in early-onset, difficult-to-control seizures, and neuro-developmental impairment. Enrollment is continuing in the study with top-line data expected in mid-2017.